89bio, Inc.

ETNBDelisted Oct 30, 2025

Industry: Pharmaceutical Preparations
SEC CIK: 0001785173

SEC filings (opens in a new tab)

89bio, Inc. was delisted on Oct 30, 2025; its insiders filed their last Form 4 on Nov 3, 2025; 198 institutions reported holding it in 13F filings for Q3 2025, worth $2.27B in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding 89bio, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021 All holders in Q1 2021

13F holders of ETNB: Q1 2021 compared with Q2 2021
Measure	Q1 2021	Q2 2021	Change
Holders	67	49	−18
Shares	16.9M	16.9M	−58.7K (−0.3%)
Value	$400.6M	$315.2M	−$85.4M (−21.3%)

New holders (2)

Institutions that held 89bio, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to ETNB in Q2 2021
Institution	Shares	Value	% of portfolio
Candriam Luxembourg S.C.A.	373,473	$6.98M	0.05%
Orchard Capital Managment, LLC	150,193	$2.81M	0.81%

Sold out (20)

Institutions that held 89bio, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of ETNB in Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
Acuta Capital Partners, LLC	393,548	$9.32M
Verition Fund Management LLC	106,731	$2.53M
Millennium Management LLC	104,013	$2.46M
Norges Bank	49,300	$1.17M
Invesco Ltd.	33,299	$789.0K
Gilder Gagnon Howe & Co LLC	30,916	$732.0K
ETF Managers Group, LLC	28,467	$675.0K
Raymond James & Associates	22,985	$544.0K
Gsa Capital Partners LLP	17,761	$421.0K
Squarepoint Ops LLC	17,527	$415.0K
Marshall Wace North America L.P.	15,923	$377.0K
Susquehanna International Group, LLP	14,968	$354.0K
Phoenix Holdings Ltd.	14,150	$336.0K
Cubist Systematic Strategies, LLC	13,560	$321.0K
California Public Employees Retirement System	13,200	$313.0K
Chicago Partners Investment Group LLC	8,688	$225.0K
Price T Rowe Associates Inc	8,513	$202.0K
Van Eck Associates Corp	3,315	$78.0K
Bank of Montreal	244	$6.00K
Point72 Hong Kong Ltd	257	$6.00K